Skip to content

Effect of esketamine on postoperative recovery quality of patients undergoing spinal surgery

Effect of esketamine on postoperative recovery quality of patients undergoing spinal surgery

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600129254
Enrollment
Unknown
Registered
2026-08-01
Start date
2026-08-14
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lumbar spondylolisthesis

Interventions

Control group ( group D ):On the basis of conventional anesthesia induction and maintenance, the control group was given the same dose of normal saline instead of esketamine for injection.
Esketamine group ( group A ):On the basis of conventional anesthesia induction and maintenance, patients in the esketamine group were additionally given a 0.2 mg/kg intravenous injection of esketamine

Sponsors

The First Affiliated Hospital of Guilin Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1.Age >= 18 years old; 2.ASA grade I-III; 3.Spinal surgery under general anesthesia; 4.To correctly understand the relevant assessment scale of this study.

Exclusion criteria

Exclusion criteria: 1.To study the history of drug allergy; 2. Patients with mental illness or preoperative use of psychotropic drugs; 3. patients with severe heart, lung, liver and kidney dysfunction; 4. Those with a serious risk of elevated blood pressure or intracranial pressure; 5. Patients with poorly controlled or untreated hypertension (resting systolic / diastolic blood pressure > 180 / 100mmHg); 6. pregnant women and lactating women; 7. untreated or inadequately treated hyperthyroidism; 8. Emergency surgery.

Design outcomes

Primary

MeasureTime frame
Postoperative quality of recovery scores;

Secondary

MeasureTime frame
NRS pain score;Hospital anxiety and depression rating scale;Safety indicators: Adverse events (AE), serious adverse events (SAE), abnormal laboratory tests, intervention-related complications.;

Countries

China

Contacts

Public ContactQin Chaosheng

The First Affiliated Hospital of Guilin Medical University

qcs823@163.com+86 773 2823244

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Aug 10, 2026